Michele Guida Selected Research

Michele Guida Research Topics

Disease

63	Melanoma (Melanoma, Malignant) 03/2024 - 03/2002
23	Neoplasms (Cancer) 03/2024 - 10/2007
8	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 07/2013
8	Brain Neoplasms (Brain Tumor) 03/2024 - 05/2014
5	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2019
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022 - 01/2020
3	Hemangiosarcoma (Angiosarcoma) 01/2020 - 02/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 01/2005
2	Leiomyosarcoma 01/2023 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 11/2019
2	Carcinogenesis 09/2020 - 05/2016
2	Liposarcoma 01/2020 - 07/2013
2	Disease Progression 05/2014 - 08/2006
1	Human Influenza (Influenza) 07/2023
1	Heart Failure 04/2023
1	Heart Diseases (Heart Disease) 04/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Acidosis 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Pemphigus (Pemphigus Vulgaris) 01/2021
1	Uveal melanoma 01/2021
1	Hemorrhage 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Hypoxia (Hypoxemia) 12/2020
1	Cryptogenic Organizing Pneumonia 12/2020
1	Vitiligo 01/2020
1	COVID-19 01/2020
1	Lymphocytosis 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Thymoma (Thymic Carcinoma) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Merkel Cell Carcinoma 01/2020

Drug/Important Bio-Agent (IBA)

19	IpilimumabIBA 03/2024 - 11/2011
14	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2005
11	NivolumabIBA 03/2024 - 01/2019
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 11/2015
7	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023 - 01/2005
7	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2019
6	VemurafenibIBA 01/2022 - 01/2014
5	dabrafenibIBA 12/2023 - 01/2014
4	cemiplimabIBA 05/2022 - 01/2021
4	Monoclonal AntibodiesIBA 01/2021 - 11/2011
4	fotemustine (Muphoran)IBA 01/2021 - 04/2009
4	Interleukin-2 (IL2)IBA 04/2009 - 03/2002
3	trametinibIBA 12/2023 - 01/2018
3	Dacarbazine (DIC)FDA LinkGeneric 01/2023 - 03/2002
3	Temozolomide (Temodar)FDA LinkGeneric 05/2018 - 08/2004
2	Propranolol (Inderal)FDA LinkGeneric 01/2023 - 01/2020
2	TrabectedinIBA 01/2023 - 07/2013
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2023 - 01/2020
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2019
2	MicroRNAs (MicroRNA)IBA 09/2020 - 01/2015
2	pembrolizumabIBA 01/2020 - 01/2020
2	Angiogenesis InhibitorsIBA 01/2020 - 02/2014
2	Docetaxel (Taxotere)FDA Link 01/2020 - 06/2015
2	CateninsIBA 11/2019 - 11/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 02/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 11/2016 - 01/2015
2	Ifosfamide FDA LinkGeneric 07/2013 - 12/2005
2	Cisplatin (Platino)FDA LinkGeneric 04/2009 - 03/2002
2	Interferon-alpha (Interferon Alfa)IBA 04/2009 - 08/2004
2	CytokinesIBA 10/2007 - 08/2006
2	InterferonsIBA 02/2006 - 03/2002
2	Fibrinogen (Factor I)FDA Link 01/2005 - 12/2003
1	SteroidsIBA 01/2024
1	W 12IBA 01/2024
1	binimetinibIBA 10/2023
1	encorafenibIBA 10/2023
1	Antiviral Agents (Antivirals)IBA 07/2023
1	VaccinesIBA 07/2023
1	SolutionsIBA 04/2023
1	MethyltransferasesIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	nirogacestatIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	Desmoglein 1IBA 01/2021
1	AutoantibodiesIBA 01/2021
1	RadonIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	2,6-dinitrotoluene (DNT)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	cobimetinibIBA 01/2021
1	ProcalcitoninIBA 12/2020
1	Circular RNAIBA 09/2020
1	AntibodiesIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	LigandsIBA 01/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020
1	SuspensionsIBA 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020

Therapy/Procedure

32	Therapeutics 01/2024 - 02/2006
22	Immunotherapy 01/2024 - 01/2005
15	Drug Therapy (Chemotherapy) 03/2024 - 03/2002
3	Radiotherapy 11/2021 - 01/2020
1	Heart Transplantation (Grafting, Heart) 04/2023
1	Adjuvant Chemotherapy 01/2020